ENVB: Enveric Earnings per share for the last twelve months

Official company branding of Enveric Biosciences Inc (ENVB)

Enveric Biosciences focuses on pre-commercial research, which leads to full capital depletion in the absence of revenue. The development of psychedelics is independent of economic conditions, relying instead on clinical trial data. The PsyAI platform automates molecule discovery using AI. TTM earnings per share dynamics help filter out speculation, with the value fixed at -16.32.

ENVB (Enveric Biosciences) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/14/2026

Enveric Biosciences Inc - analytical breakdowns and key metrics (ENVB)

- current quotes and average value forecast:
Price Chart Enveric Biosciences|ENVB - Fair Value Consensus
- market capitalization information:
Market Value Enveric Biosciences, Inc.|ENVB - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Enveric Biosciences|ENVB - Total Stockholders' Equity|Market Value to Book Value Ratio enveric.com|ENVB - Total Business Assets
- debt and liquidity data:
Total Debt to Equity Ratio Enveric Biosciences|ENVB - Long-Term Debt to Equity|Short-Term Debt to Capital Enveric|ENVB - Company Cumulative Debt|Debt to Book Capitalization Ratio Enveric Biosciences, Inc.|ENVB - Company Long-Term Loans and Borrowings|Company Short-Term Debts Enveric Biosciences|Quick Ratio enveric.com
- net income and valuation multiples indicators:
ENVB - Net Income|Future Profit Enveric Biosciences|ENVB - Company Value to Net Income|Forward P/E Multiple Enveric Biosciences, Inc.|ENVB - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Enveric Biosciences, Inc.|ENVB - Operating income before deduction of amortization|Earnings per share for the last twelve months Enveric Biosciences|ENVB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months enveric.com|ENVB - Expected net earnings per share growth this year|Earnings growth forecast for next year Enveric Biosciences
- revenue and sales proceeds data:
ENVB - Company Sales|Projected Sales Volume Enveric Biosciences|ENVB - Price-to-Revenue Coefficient|Forward P/S Multiple Enveric Biosciences, Inc.
Basic company analysis:ENVB - Enveric Biosciences
Flagship merchandise of Enveric Biosciences Inc

For Enveric Biosciences (ENVB), a leader in developing evidence-based psychedelic therapies, this indicator serves as a measure of actual capitalization efficiency. The calculation is based on dividing total annual net income by the total number of shares. By analyzing changes in the rolling annual EPS, an investor can see the actual equity return of the business. This metric separates market expectations from financial reality, allowing for an assessment of the value of innovation in the context of profit.

Competing companies

INDV - Earnings per share for the last twelve months|Earnings per share for the trailing year COLL (collegiumpharma.com)|Cronos Group (CRON) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Canopy Growth Corp|HITI (High Tide Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Aurora ACB|Earnings per share for the last twelve months Achieve Life Sciences (ACHV)|Skye Bioscience Inc. - Earnings per share for the last 12 months|Anebulo Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|InterCure Ltd - Earnings per share for the last twelve months|Nutriband Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Nasus Pharma Ltd|igcinc.us (IGC) - Earnings per share for the last twelve months|MIRA Pharmaceuticals, Inc. - Earnings per share for the trailing year|FLGC (Flora Growth) - Net earnings per share (EPS TTM)|IMC (IMCC) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) ADIL|Net earnings per share for the last 12 months artelobio.com ARTL|Ensysce Biosciences, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|Greenlane - Net earnings per share (EPS TTM)|INM: Earnings per share for the last twelve months|AKAN: Net earnings per share (EPS TTM)|BGXX - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Hempacco Co., Inc.